Cost analysis for cancer subgroups

British Journal of Cancer

Volumn 100, Issue 9, 2009, Pages 1513-

  Hall, P S ^a   Rautenberg, T A ^a   McCabe, C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB;

BREAST CANCER; CANCER RELAPSE; CLINICAL DECISION MAKING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; ADULT; AGED; BREAST TUMOR; COHORT ANALYSIS; COST; ECONOMICS; FEMALE; HOSPITAL COST; MIDDLE AGED; MORTALITY; NOTE; UNITED KINGDOM;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; COSTS AND COST ANALYSIS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; MIDDLE AGED;

EID: 65549146235     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605035     Document Type: Letter

References (4)

1. Dent R, Hanna WM, Trudeau M, Rawlinson E, Sun P, Narod SA (2008) Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat [E-pub ahead of print]
2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406: 747-752
3. Shang B, Goldman D (2007) Does age or life expectancy better predict health care expenditures? Health Econ 17: 487-501
4. Thomas RJ, Williams M, Marshall C, Glen J, Callam M (2009) The total hospital and community UK costs of managing patients with relapsed breast cancer. Br J Cancer 100: 598-600